A smart beta exchange traded fund, the Invesco S&P 500 Equal Weight Health Care ETF (RSPH) debuted on 11/01/2006, and offers broad exposure to the Health Care ETFs category of the market.
The Invesco S&P 500 Equal Weight Health Care ETF (RSPH) was launched on November 1, 2006, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Broad segment of the equity market.
The Invesco S&P 500 Equal Weight Health Care ETF (RSPH) made its debut on 11/01/2006, and is a smart beta exchange traded fund that provides broad exposure to the Health Care ETFs category of the market.
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| TJD Thomas John Drogan PR Inc.IPAL SECURITIES Inc. | 17,597 | $559,413.32 | $594,426.66 | $35,013.34 | 6.26% |
| TMB Timothy M. Bidwell Hazlett, BURT & WATSON Inc. | 1,000 | $31,850 | $33,780 | $1,930 | 6.06% |
| CE Curtis Ellergodt Rothschild Investment LLC | 700 | $20,846 | $23,646 | $2,800 | 13.43% |
| JD Jim Dushek HARBOUR INVESTMENTS Inc. | 3,971 | $117,665.72 | $134,259.51 | $16,593.79 | 14.1% |
Point72 Asset Management LP Point72 Asset Management LP | 6,814 | $205,739 | $230,142.85 | $24,403.85 | 11.86% |
| ARCA Exchange | US Country |
The company operates a fund that primarily focuses on investing in the healthcare sector, specifically targeting securities listed within the S&P 500® Health Care Index. This targeted approach ensures that the fund invests at least 90% of its assets into securities that are part of this underlying index, which is a subset of the broader S&P 500® Index. The S&P 500® Health Care Index is designed to track the performance of companies classified within the healthcare sector according to the Global Industry Classification Standard (GICS®), ensuring that investments are directed towards firms engaged in healthcare and related activities.
The core service offered involves the investment in securities that form part of the S&P 500® Health Care Index. By focusing on this segment, the fund aims to capture the growth and performance of the healthcare sector within the US economy, capitalizing on the dynamic nature of companies involved in healthcare, pharmaceuticals, medical technology, and related services.
This product leverages an index-based investment strategy, focusing specifically on the components of the S&P 500® Health Care Index. Such an approach ensures a diversified exposure to the healthcare sector, mirroring the performance of its underlying index. This strategy aims to offer investors a balanced mix of growth, income, and stability by investing in a sector known for its resilience and innovation.